SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-021096
Filing Date
2024-05-23
Accepted
2024-05-23 08:00:29
Documents
13
Period of Report
2024-05-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38497
  Complete submission text file 0001493152-24-021096.txt   214010

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE envb-20240521.xsd EX-101.SCH 3012
3 XBRL LABEL FILE envb-20240521_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE envb-20240521_pre.xml EX-101.PRE 22357
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3827
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 24975238
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)